Juan José Soler‐Cataluña

14.3k total citations · 2 hit papers
200 papers, 8.7k citations indexed

About

Juan José Soler‐Cataluña is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Juan José Soler‐Cataluña has authored 200 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 184 papers in Pulmonary and Respiratory Medicine, 101 papers in Physiology and 20 papers in Epidemiology. Recurrent topics in Juan José Soler‐Cataluña's work include Chronic Obstructive Pulmonary Disease (COPD) Research (169 papers), Respiratory Support and Mechanisms (79 papers) and Asthma and respiratory diseases (79 papers). Juan José Soler‐Cataluña is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (169 papers), Respiratory Support and Mechanisms (79 papers) and Asthma and respiratory diseases (79 papers). Juan José Soler‐Cataluña collaborates with scholars based in Spain, United Kingdom and United States. Juan José Soler‐Cataluña's co-authors include Miguel Ángel Martínez‐García, Marc Miravitlles, Pilar Román-Sánchez, Myriam Calle Rubio, Joan B. Soriano, Miguel Perpiñá-Tordera, Pablo Catalán, Julio Ancochea, Pere Almagro and Borja G. Cosío and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Juan José Soler‐Cataluña

190 papers receiving 8.4k citations

Hit Papers

Severe acute exacerbations and mortality in patients with... 2005 2026 2012 2019 2005 2017 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
    2005 1.4k citations Juan José Soler‐Cataluña profile →
  2. Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable
    2017 294 citations Marc Miravitlles, Juan José Soler‐Cataluña et al. Archivos de Bronconeumología profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan José Soler‐Cataluña Spain 45 7.6k 4.0k 1.0k 771 620 200 8.7k
María Montes de Venezuela 40 7.4k 1.0× 3.3k 0.8× 728 0.7× 185 0.2× 470 0.8× 125 8.9k
Ciro Casanova Spain 42 8.5k 1.1× 3.6k 0.9× 911 0.9× 150 0.2× 378 0.6× 132 9.8k
Gary T. Ferguson United States 40 10.1k 1.3× 7.1k 1.8× 576 0.6× 178 0.2× 500 0.8× 188 11.4k
P. Vermeire Belgium 35 4.5k 0.6× 3.4k 0.9× 413 0.4× 330 0.4× 440 0.7× 105 6.7k
Peter Frith Australia 33 3.9k 0.5× 2.7k 0.7× 517 0.5× 126 0.2× 180 0.3× 117 5.7k
Antonio Anzueto United States 22 4.4k 0.6× 1.7k 0.4× 612 0.6× 99 0.1× 295 0.5× 52 5.3k
Philip H. Quanjer Netherlands 32 6.2k 0.8× 3.2k 0.8× 541 0.5× 271 0.4× 296 0.5× 66 7.6k
Paul Hernandez Canada 38 4.2k 0.5× 2.2k 0.5× 452 0.4× 92 0.1× 210 0.3× 125 5.3k
Christine F. McDonald Australia 46 4.9k 0.6× 1.5k 0.4× 598 0.6× 151 0.2× 136 0.2× 253 7.0k
Hana Müllerová United Kingdom 37 5.8k 0.8× 2.7k 0.7× 908 0.9× 42 0.1× 490 0.8× 140 6.5k

Countries citing papers authored by Juan José Soler‐Cataluña

Since Specialization
Citations

This map shows the geographic impact of Juan José Soler‐Cataluña's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan José Soler‐Cataluña with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan José Soler‐Cataluña more than expected).

Fields of papers citing papers by Juan José Soler‐Cataluña

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan José Soler‐Cataluña. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan José Soler‐Cataluña. The network helps show where Juan José Soler‐Cataluña may publish in the future.

Co-authorship network of co-authors of Juan José Soler‐Cataluña

This figure shows the co-authorship network connecting the top 25 collaborators of Juan José Soler‐Cataluña. A scholar is included among the top collaborators of Juan José Soler‐Cataluña based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan José Soler‐Cataluña. Juan José Soler‐Cataluña is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soler‐Cataluña, Juan José, et al.. (2025). Risk validation of a new quantitative score for clinical control of chronic obstructive pulmonary disease: The RADAR score. Archivos de Bronconeumología. 62(1). 28–34. 2 indexed citations
2.
Almagro, Pere, et al.. (2024). Impact of comorbidities in COPD clinical control criteria. The CLAVE study. BMC Pulmonary Medicine. 24(1). 6–6. 18 indexed citations
3.
Bernabéu-Mora, Roberto, et al.. (2024). Five-Repetition Sit-to-Stand Test as Predictor of Mortality in High Risk COPD Patients. Archivos de Bronconeumología. 61(2). 90–95. 2 indexed citations
4.
Bernabéu-Mora, Roberto, Silvana Loana de Oliveira-Sousa, Francesc Medina‐Mirapeix, et al.. (2024). Identifying COPD patients with poor health status and low exercise tolerance through the five-repetition sit-to-stand test and modified Medical Research Council Dyspnea Score. European Journal of Internal Medicine. 125. 51–56.
5.
García‐Río, Francisco, Marc Miravitlles, Joan B. Soriano, et al.. (2023). Dissociation between physical capacity and daily physical activity in COPD patients. A population-based approach. Respiratory Medicine. 207. 107115–107115. 4 indexed citations
6.
Soler‐Cataluña, Juan José, Luís Puente‐Maestu, Miguel Román-Rodríguez, et al.. (2022). Validation of the Spanish Activity Questionnaire in COPD (SAQ-COPD) in Patients with Chronic Obstructive Pulmonary Disease. International Journal of COPD. Volume 17. 2835–2846. 3 indexed citations
7.
Cosío, Borja G., Hanaa Shafiek, Núria Toledo-Pons, et al.. (2021). Characterization of COPD Admissions During the First COVID-19 Outbreak. International Journal of COPD. Volume 16. 1549–1554. 7 indexed citations
8.
Miravitlles, Marc, Myriam Calle Rubio, Jesús Molina, et al.. (2021). Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable. Archivos de Bronconeumología. 58(1). 69–81. 111 indexed citations
9.
Martínez‐García, Miguel Ángel, Rosa Faner, Grace Oscullo, et al.. (2020). Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis. American Journal of Respiratory and Critical Care Medicine. 201(9). 1078–1085. 65 indexed citations
10.
Miravitlles, Marc, Paweł Śliwiński, Richard W. Costello, et al.. (2019). <p>Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter study</p>. International Journal of COPD. Volume 14. 1595–1601. 10 indexed citations
11.
Ancochea, Julio, José Luís Izquierdo Alonso, José Miguel Rodríguez González-Moro, et al.. (2018). Diagnóstico, estratificación, tratamiento y seguimiento de los pacientes con EPOC en función de su complejidad: Proyecto Expert Meeting. 4.
12.
Soler‐Cataluña, Juan José, et al.. (2018). Validation of clinical control in COPD as a new tool for optimizing treatment. International Journal of COPD. Volume 13. 3719–3731. 41 indexed citations
13.
Cosío, Borja G., Joan B. Soriano, José Luís López-Campos, et al.. (2016). Distribution and Outcomes of a Phenotype-Based Approach to Guide COPD Management: Results from the CHAIN Cohort. PLoS ONE. 11(9). e0160770–e0160770. 45 indexed citations
14.
Martínez‐García, Miguel Ángel, David de la Rosa, Juan José Soler‐Cataluña, et al.. (2013). Prognostic Value of Bronchiectasis in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 187(8). 823–831. 224 indexed citations
15.
Martínez‐García, Miguel Ángel, Francisco Campos‐Rodríguez, Pablo Catalán, et al.. (2012). Cardiovascular Mortality in Obstructive Sleep Apnea in the Elderly: Role of Long-Term Continuous Positive Airway Pressure Treatment: A Prospective Observational Study. American Journal of Respiratory and Critical Care Medicine. 186(9). 909–916. 220 indexed citations
16.
Miravitlles, Marc, et al.. (2012). Previous outpatient antibiotic use in patients admitted to hospital for COPD exacerbations: room for improvement. Infection. 41(2). 361–370. 2 indexed citations
17.
Catalán, Pablo, Alberto Herrejón, Miguel Ángel Martínez‐García, et al.. (2012). Consistencia interna y validez de la versión española del cuestionario de calidad de vida específico para el síndrome de apnea del sueño: Sleep Apnoea Quality of Life Index. Archivos de Bronconeumología. 48(12). 431–442. 11 indexed citations
18.
Martínez‐García, Miguel Ángel & Juan José Soler‐Cataluña. (2010). Bronquiectasias: valoración y tratamiento. Jano: Medicina y humanidades. 67–73.
19.
Martínez‐García, Miguel Ángel, Juan José Soler‐Cataluña, Pilar Román-Sánchez, et al.. (2009). Continuous Positive Airway Pressure Treatment Reduces Mortality in Patients with Ischemic Stroke and Obstructive Sleep Apnea: A 5-Year Follow-up Study. American Journal of Respiratory and Critical Care Medicine. 180(1). 36–41. 273 indexed citations
20.
Soler‐Cataluña, Juan José & Miguel Ángel Martínez‐García. (2008). Metodología e impacto clínico de los estudios de mortalidad en la EPOC. Archivos de Bronconeumología. 44. 21–28. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Montes de Breakdown of academic impact, for papers by Ciro Casanova Breakdown of academic impact, for papers by Gary T. Ferguson Breakdown of academic impact, for papers by P. Vermeire Breakdown of academic impact, for papers by Peter Frith Breakdown of academic impact, for papers by Antonio Anzueto Breakdown of academic impact, for papers by Philip H. Quanjer Breakdown of academic impact, for papers by Paul Hernandez Breakdown of academic impact, for papers by Christine F. McDonald Breakdown of academic impact, for papers by Hana Müllerová
Rankless by CCL
2026